Day: October 28, 2026

Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal of Chronic Wound Care Management & Research

Published multicenter clinical trial data demonstrate higher wound closure rates and greater wound area reduction with XWRAP® plus standard of...

Vivex Biologics’ VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine

The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of...

Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome

HealthCore Foundation Announces Nearly $250 Million Real Estate Transaction with Northbay Health to Support Outpatient Expansion in Northern California

11-property Northern California portfolio will support outpatient expansion and is projected to reduce Northbay Health's occupancy costs by more than...

Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program

Advancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory PatientsREHOVOT, Israel, Oct....

error: Content is protected !!